The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for <i>Helicobacter pylori</i> Eradication: A Randomized, Double-Blind Clinical Trial

<div>Flow chart for the process of patient randomization. ITT: intention-to-treat, PP: per-protocol, ADRs: adverse drug reactions, and BPAL-7 and BPAL-10: bismuth-based quadruple therapy containing pantoprazole, amoxicillin, and levofloxacin for seven and ten days, respectively.</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for <i>Helicobacter pylori</i> Eradication: A Randomized, Double-Blind Clinical Trial 

Figure 1 | The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter pylori Eradication: A Randomized, Double-Blind Clinical Trial 